Detalles de la búsqueda
1.
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Blood
; 119(14): 3276-84, 2012 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22337718
2.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Lancet Oncol
; 9(2): 105-16, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18226581
3.
Treatment strategies in follicular lymphomas: current status and future perspectives.
J Clin Oncol
; 23(26): 6394-9, 2005 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16155025
4.
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines.
Hematol J
; 5(1): 61-8, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14745432
5.
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Cancer
; 107(5): 1014-22, 2006 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16878325
6.
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.
Blood
; 101(2): 699-702, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12393524
Resultados
1 -
6
de 6
1
Próxima >
>>